Discharged on Antithrombotic Therapy

Identifying Attributes

Care Settings
Hospital Care
Country
United States of America
Publishing Organisation
Centers for Medicare & Medicaid Services (CMS): Eligible Hospital / Critical Access Hospital eCQMs
Type of Quality Indicator
Process
IOM Quality Dimension
Effectiveness
Domain
Medications and Medication Management

Defining Attributes

Definition

Ischaemic stroke patients prescribed or continuing to take antithrombotic therapy at hospital discharge.

Numerator

Inpatient hospitalisations for patients prescribed or continuing to take antithrombotic therapy at hospital discharge.

Denominator

Inpatient hospitalisations (non-elective admissions) for patients age 18 and older, discharged from inpatient care with a principal diagnosis of ischaemic stroke, ending during the measurement period.

Exclusions

• Inpatient hospitalisations for patients admitted for elective carotid intervention. This exclusion is implicitly modelled by only including non-elective hospitalisations. • Inpatient hospitalisations for patients discharged to another hospital • Inpatient hospitalisations for patients who left against medical advice • Inpatient hospitalisations for patients who expired • Inpatient hospitalisations for patients discharged to home for hospice care • Inpatient hospitalisations for patients discharged to a health care facility for hospice care • Inpatient hospitalisations for patients with comfort measures documented

Use of Risk Adjustment
No
Risk Adjustments

None

Stratifications

None

Collection and Reporting Attributes

Type of Data Collection
Data Collection Methods
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Annually
Reporting Frequency in Days
365
Indicator Has Recommended Targets
No

Source and Reference Attributes

Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025